Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. XXII
XXII logo

XXII Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.639
Open
0.616
VWAP
0.61
Vol
277.96K
Mkt Cap
6.51M
Low
0.594
Amount
170.89K
EV/EBITDA(TTM)
--
Total Shares
--
EV
8.29M
EV/OCF(TTM)
--
P/S(TTM)
0.02
22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The Company manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The Company's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The Company operates through a single segment named Tobacco. It is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. It is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.
Show More

Events Timeline

(ET)
2026-05-07
06:30:00
22nd Century Reports Q1 Revenue of $4.1M
select
2026-04-23 (ET)
2026-04-23
08:00:00
22nd Century Signs Testing Services Agreement with North Carolina State University
select
2026-04-07 (ET)
2026-04-07
08:20:00
22nd Century Launches 100mm VLN Reduced Nicotine Cigarette
select
2026-03-31 (ET)
2026-03-31
17:10:00
22nd Century Files $250M Mixed Securities Shelf
select
2026-03-26 (ET)
2026-03-26
06:10:00
Company Reports Q4 Revenue of $3.54M
select
2026-02-23 (ET)
2026-02-23
17:20:00
22nd Century Reports Strong Sales Momentum for VLN Low Nicotine Cigarettes in U.S.
select
2026-02-20 (ET)
2026-02-20
16:30:00
22nd Century Group Expects Net Loss of $2.8M
select
2026-01-23 (ET)
2026-01-23
20:00:00
22nd Century Trading Halted, News Pending
select
2026-01-15 (ET)
2026-01-15
09:10:00
22nd Century Group Outlines Strategic Focus and Financial Foundation for 2026
select

News

Newsfilter
8.5
05-12Newsfilter
FDA Files Renewal Applications for VLN® Tobacco Products
  • Regulatory Progress: The FDA has accepted 22nd Century Group's MRTP renewal applications for VLN®King and VLN®Menthol King, marking a significant advancement in the company's tobacco harm reduction efforts, with expectations for continued market authorization.
  • Market Data Support: The renewal submission includes a 2024 study indicating a 40% reduction in daily cigarette consumption over 12 weeks among smokers using VLN® cigarettes, providing strong support for the long-term commercial and regulatory case for the product.
  • Unique Product Positioning: VLN® cigarettes contain 95% less nicotine than traditional cigarettes, with the FDA noting that using such products could help reduce nicotine dependence, further solidifying the company's competitive advantage in the tobacco market.
  • Public Engagement: The FDA has begun releasing application materials for public access and opened a docket for public comments, allowing stakeholders to participate in the scientific review process, which enhances the rigor of the FDA's regulatory framework and provides transparency and trust for the company.
seekingalpha
9.5
05-07seekingalpha
22nd Century Group Reports Disappointing Q1 Earnings
  • Earnings Miss: 22nd Century Group reported a Q1 GAAP EPS of -$5.07, missing expectations by $3.87, indicating significant challenges in profitability that could undermine investor confidence.
  • Revenue Decline: The company generated $4.11 million in revenue for Q1, a 31% year-over-year decrease that fell short of the $4.6 million forecast, reflecting poor market performance and potential liquidity issues ahead.
  • Stock Reaction: Following the earnings report, shares of 22nd Century dropped 18% in after-hours trading, signaling heightened investor concerns about the company's growth prospects, which may impact its financing capabilities and competitive position.
  • Future Strategy: Despite the disappointing earnings, 22nd Century plans to launch Pinnacle Pure in 2026 and double its store count, demonstrating a long-term strategic intent to expand in the VLN market; however, short-term financial pressures may hinder execution capabilities.
moomoo
9.5
05-07moomoo
22ND CENTURY GROUP INC Reports Q1 EPS from Continuing Operations at $-5.07
  • Financial Performance: Century Group Inc. reported earnings per share (EPS) of $5.07 for the first quarter.
  • Market Context: The EPS figure reflects the company's performance amidst current market conditions.
moomoo
9.5
05-07moomoo
22ND CENTURY GROUP INC Reports Q1 Net Revenues Rise to $4.1 Million from $3.5 Million
  • Revenue Growth: Century Group Inc. reported a net revenue increase to $4.1 million, up from $3.5 million.
  • Financial Performance: The significant rise in revenue indicates a positive trend in the company's financial performance for the quarter.
seekingalpha
9.5
05-06seekingalpha
22nd Century to Announce Q1 Earnings on May 7
  • Earnings Announcement Schedule: 22nd Century is set to release its Q1 2023 earnings report on May 7 before market open, with consensus EPS estimate at -$1.20 and revenue expected at $4.61 million, reflecting a 22.7% year-over-year decline, indicating significant profitability challenges ahead.
  • Historical Performance Review: Over the past two years, 22nd Century has failed to meet EPS estimates 100% of the time, although it has surpassed revenue expectations 75% of the time, highlighting a relative strength in revenue management but a pressing need for improvement in profitability.
  • Market Reaction Analysis: The company's reduced nicotine strategy has not gained investor confidence, leading to poor stock performance, which may impact its future financing capabilities and market expansion plans.
  • Future Strategic Planning: 22nd Century aims to double its store count and launch the Pinnacle Pure product by 2026 to drive VLN market expansion; if successful, this strategy could enhance market share and brand influence.
Newsfilter
8.5
04-29Newsfilter
22nd Century Group Outlines 2026 Strategy and Shareholder Value Initiatives
  • Market Opportunity: With approximately 28 million smokers in the U.S. and 70% wanting to quit, 22nd Century Group's VLN® cigarettes, containing 95% less nicotine, cater to this demand for healthier options, potentially driving significant sales growth.
  • Product Innovation: The VLN® cigarette is the only FDA-authorized low-nicotine combustible cigarette, proven to help smokers reduce nicotine intake after 28 years of research, establishing the company as a leader in tobacco harm reduction.
  • Marketing Expansion: In 2026, the company plans to increase its retail footprint and enhance sales density in existing markets, which is expected to significantly boost awareness of VLN® products and help carve out new market niches in the competitive tobacco industry.
  • Long-term Value Creation: The company is committed to driving long-term shareholder value through a diversified low-nicotine product portfolio and strong distribution networks, ensuring all stakeholders understand the importance of its technology in transforming smoking and nicotine addiction.

Valuation Metrics

The current forward P/E ratio for 22nd Century Group Inc (XXII.O) is -0.00, compared to its 5-year average forward P/E of -37.04. For a more detailed relative valuation and DCF analysis to assess 22nd Century Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-37.04
Current PE
-0.00
Overvalued PE
50.62
Undervalued PE
-124.71

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-3.09
Current EV/EBITDA
-0.91
Overvalued EV/EBITDA
-0.21
Undervalued EV/EBITDA
-5.97

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.00
Current PS
0.09
Overvalued PS
7.04
Undervalued PS
-1.05

Financials

AI Analysis
Annual
Quarterly

Whales Holding XXII

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is 22nd Century Group Inc (XXII) stock price today?

The current price of XXII is 0.61 USD — it has decreased -3.02

What is 22nd Century Group Inc (XXII)'s business?

22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The Company manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The Company's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The Company operates through a single segment named Tobacco. It is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. It is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.

What is the price predicton of XXII Stock?

Wall Street analysts forecast XXII stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for XXII is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is 22nd Century Group Inc (XXII)'s revenue for the last quarter?

22nd Century Group Inc revenue for the last quarter amounts to 2.27M USD, decreased -26.23

What is 22nd Century Group Inc (XXII)'s earnings per share (EPS) for the last quarter?

22nd Century Group Inc. EPS for the last quarter amounts to -2.50 USD, decreased -99.37

How many employees does 22nd Century Group Inc (XXII). have?

22nd Century Group Inc (XXII) has 56 emplpoyees as of May 21 2026.

What is 22nd Century Group Inc (XXII) market cap?

Today XXII has the market capitalization of 6.51M USD.